期刊文献+

鲑鱼降钙素对绝经后骨质疏松骨代谢及相关指标的影响 被引量:4

Effect of calcitonin on bone metabolism and related markers in postmenopausal osteoporosis
下载PDF
导出
摘要 目的 观察鲑鱼降钙素对患者绝经后骨质疏松(PMOP)的作用。方法 将 70例PMOP患者随机分成 2组 ,降钙素组 39例 ,鲑鱼降钙素肌注 ,每次 5 0IU ,隔日 1次 ;同时 ,每日加服钙尔奇 D 1片。对照组 31例 ,每日予 1片钙尔奇D ,疗程均为 6个月。用药前后测定腰椎L2~ 4 及股骨近端骨密度 (BMD)、血清骨钙蛋白 (BGP)、碱性磷酸酶 (AKP)、尿脱氧吡啶啉 /肌酐 (DPD/CR)比值。结果 降钙素组腰椎L2 4 BMD上升明显 ,股骨近端BMD升高不明显 ,血清BGP、ALP、及DPD/CR比值降低 (P <0 0 5 )。对照组药物治疗后无改善。结论 鲑鱼降钙素能够增加PMOP患者腰椎BMD ,抑制骨吸收 ,降低骨转换 ,促进骨形成。 Objective To observe the effect of calcitonin on postmennopausal osteoporosis (PMOP). Methods 70 cases of PMOP patients were randomly divided into calcitonin and control groups. The 39 patients in calcitonin group were injected 50 IU calcitonin every other day and orally given caltrate with vitamin D one Tablet every day. The 31 patients of the control group took only caltrate with vitamin D one tablet every day. The duration of the treatment was 6 months. Bone mineral density(BMD), serum osteocalin (BGP), alkaline(AKP) and u-deoxypyridinoline proline to urine creatinine (DPD/CR) were detected before and after treatment.Results Average BMD from the second to the fourth lumbar with anteroposterior position in the treatment group increased significantly (P<0.01). Change in hip BMD was not significant. Serum levels of BGP AKP and urea DPD/CR decreased (P<0.05). No remarkable changes was observed the after treatment in the control group.Conclusion Alcitonin is effective in increasing BMD of lumbar vertebra in PMOP patients, decreasing bone absorption and improving bone formation.
出处 《安徽医科大学学报》 CAS 2002年第6期468-470,共3页 Acta Universitatis Medicinalis Anhui
关键词 骨质疏松 绝经后 代谢 骨密度 药物作用 降钙素 osteoporosis,postmeno pausal/matelism bone density/drug effects calcitonin
  • 相关文献

参考文献6

二级参考文献38

  • 1邝建,王敏霓,王声涌,崔长安,刘国宁.膳食营养在骨质疏松发生中的作用──病例对照研究及14年饮食营养改变[J].中国骨质疏松杂志,1997,3(4):47-51. 被引量:13
  • 2刘忠厚,潘子昂,王石麟,段云波,何郁泉,马海波,肖艳霞,刘京萍,王洪复,杨定焯,王际孝,郭如意,李国璋,丁桂芝,刘玉槐,倪顺梅,卢淑梅,张万钟,房德元,周倜,张芝彬,张学中,吴元沧,金信爱.骨骼生长衰老规律和原发性骨质疏松症预诊的研究[J].中国骨质疏松杂志,1995,1(1):1-7. 被引量:51
  • 3邝建,王敏霓,王声涌,崔长安,刘国宁.中老年知识分子骨质疏松危险因素病例-对照研究[J].中华内分泌代谢杂志,1996,12(1):12-16. 被引量:7
  • 41,Massey HM,Flanagan AM.Human osteoclasts derive from CD14-positive monocytes.Br J Haematol,1999,106:167-70.
  • 52,Mosekilde L,Danieslsen CC,Gasser J.The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents(estrogen and calcitonin),human parathyroid hormone(1-38),and combination therapy,assessed in aged ovariectomized rats.Endocrinology,1994,134:2126-2134.
  • 63,Monier-Faugere MC,Geng Z,Qi Q,et al.Calcitonin prevents bone loss,but decreases osteoblastic activity in ovariohysterectomized beagle dogs.J Bone Miner Res,1996,11:446-455.
  • 74,David P,Thomas MD,Monier-Faugere MC,et al.Caltonin alters bone quality in beagle dogs.J Bone Miner Res,1997,12:1936-1943.
  • 85,Liu CC.A simplified technique for temperature methymethacrylate embedding.Stain Technol.1987,62:155.
  • 96,Parfitt AM,Drezner MK,Glorieux FH,et al.Bone histomorphometry:standardization of nomenclature,symbols,and units.Report of the ASBMR Histomorhometry Nomenclature Committee.J Bone Miner Res,1987,2:595-610.
  • 107,Chambers TJ,Dunn CJ,Pharmacological control of osteoclastic mobility.Calcif Tissue Int,1983,35:566-579.

共引文献77

同被引文献33

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部